Most of the studies performed on human immune response against leishmaniasis is carried out on crude PBMCs without purifying CD4+ T cell and CD8+ population and there is no report to show a clear-cut CD4+ Th1/Th2 response [34]. This evidence concerns the gene CD8A and leishmaniasis.